Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Hims & Hers Health
(NYSE:HIMS)
Intraday
$12.31
-0.03
[-0.24%]
After-Hours
$12.31
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$12.31
-0.03
[-0.24%]
At close: Apr 25
$12.31
0
[0.00%]
PreMarket: 8:08AM EDT
Get Report
Watch
Q1 2024 Earnings in 11 days from now on Mon May 6th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Hims & Hers Health Stock (NYSE:HIMS)
Hims & Hers Health Stock (NYSE: HIMS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 16, 2024
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Benzinga Insights
-
Apr 16, 2024, 2:02PM
Hims & Hers Health shares are trading lower after Jefferies downgraded the stock from Buy to Hold.
Benzinga Newsdesk
-
Apr 16, 2024, 11:24AM
Jefferies Downgrades Hims & Hers Health to Hold, Lowers Price Target to $15
Benzinga Newsdesk
-
Apr 16, 2024, 6:47AM
Wednesday, April 10, 2024
Breaking Down Hims & Hers Health: 6 Analysts Share Their Views
Benzinga Insights
-
Apr 10, 2024, 9:00AM
Canaccord Genuity Initiates Coverage On Hims & Hers Health with Buy Rating, Announces Price Target of $20
Benzinga Newsdesk
-
Apr 10, 2024, 7:50AM
Thursday, April 04, 2024
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
Avi Kapoor
-
Apr 4, 2024, 10:44AM
A Closer Look at Hims & Hers Health's Options Market Dynamics
Benzinga Insights
-
Apr 4, 2024, 10:19AM
Wednesday, March 20, 2024
Check Out What Whales Are Doing With HIMS
Benzinga Insights
-
Mar 20, 2024, 1:02PM
Thursday, March 14, 2024
Looking Into Hims & Hers Health's Recent Short Interest
Benzinga Insights
-
Mar 14, 2024, 9:30AM
Thursday, February 29, 2024
Maize and Blue Stock Pitch Competition 2024 Showcases Analytical Excellence With Surprising Results, Including A Bearish Call
Josh Walter
-
Feb 29, 2024, 5:21PM
Tuesday, February 27, 2024
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
Avi Kapoor
-
Feb 27, 2024, 2:32PM
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Feb 27, 2024, 1:18PM
These Analysts Boost Their Forecasts On Hims & Hers After Upbeat Earnings
Avi Kapoor
-
Feb 27, 2024, 1:10PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Feb 27, 2024, 12:31PM
Why Hims & Hers Stock Is Soaring After Earnings
Erica Kollmann
-
Feb 27, 2024, 12:27PM
Crude Oil Gains 1%; Macy's Plans To Close 150 Stores
Avi Kapoor
-
Feb 27, 2024, 12:24PM
Guggenheim Maintains Buy on Hims & Hers Health, Raises Price Target to $17
Benzinga Newsdesk
-
Feb 27, 2024, 12:08PM
Citigroup Maintains Buy on Hims & Hers Health, Raises Price Target to $16
Benzinga Newsdesk
-
Feb 27, 2024, 11:57AM
Piper Sandler Maintains Neutral on Hims & Hers Health, Raises Price Target to $11
Benzinga Newsdesk
-
Feb 27, 2024, 10:33AM
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
Feb 27, 2024, 10:27AM
Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $13
Benzinga Newsdesk
-
Feb 27, 2024, 8:57AM
Market-Moving News for February 27th
Benzinga Newsdesk
-
Feb 27, 2024, 8:44AM
Hims & Hers Health shares are trading higher after the company reported better-than-expected Q4 financial results and issued strong guidance.
Benzinga Newsdesk
-
Feb 27, 2024, 8:30AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Feb 27, 2024, 8:06AM
Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 27, 2024, 7:56AM
Monday, February 26, 2024
Bitcoin Above $55K Gets Marathon, Riot Platforms Trending — Zoom Video, Hims & Hers, Tesla Also On Investors' Radars Today
Benzinga Neuro
-
Feb 26, 2024, 9:26PM
Hims & Hers Health Stock Climbs Following Q4 Earnings Beat, Revenue Beat, Guidance Above Estimates
Erica Kollmann
-
Feb 26, 2024, 4:31PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Feb 26, 2024, 4:31PM
Hims & Hers Health shares are trading higher after the company reported better-than-expected Q4 financial results and issued strong guidance.
Benzinga Newsdesk
-
Feb 26, 2024, 4:24PM
Hims & Hers Health Sees FY24 Revenue $1.17B-$1.20B Vs $1.099B Est.
Benzinga Newsdesk
-
Feb 26, 2024, 4:09PM
Hims & Hers Health Sees Q1 2024 Revenue $267M-$272M Vs $252.548M Est.
Benzinga Newsdesk
-
Feb 26, 2024, 4:09PM
Hims & Hers Health Q4 2023 GAAP EPS $0.01 Beats $(0.03) Estimate, Sales $246.62M Beat $245.82M Estimate
Benzinga Newsdesk
-
Feb 26, 2024, 4:07PM
Leerink Partners Initiates Coverage On Hims & Hers Health with Market Perform Rating, Announces Price Target of $10
Benzinga Newsdesk
-
Feb 26, 2024, 8:43AM
Earnings Scheduled For February 26, 2024
Benzinga Insights
-
Feb 26, 2024, 4:47AM
Friday, February 23, 2024
Earnings Preview: Hims & Hers Health
Benzinga Insights
-
Feb 23, 2024, 9:02AM
Friday, January 05, 2024
Tigress Financial Maintains Buy on Hims & Hers Health, Raises Price Target to $15
Benzinga Newsdesk
-
Jan 5, 2024, 10:03AM
Monday, December 25, 2023
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Dec 25, 2023, 12:35PM
Monday, December 04, 2023
Hims & Hers Launches Holistic Weight Loss Program To Break The Endless Cycle Of Weight Gain And Loss
Benzinga Newsdesk
-
Dec 4, 2023, 9:16AM
Friday, November 17, 2023
Top 5 Health Care Stocks That May Collapse In November
Lisa Levin
-
Nov 17, 2023, 8:33AM
Thursday, November 09, 2023
Himax Technologies Sees Q4 Revenues To Decline 5.0% - 11.0% Sequentially
Benzinga Newsdesk
-
Nov 9, 2023, 5:26AM
Tuesday, November 07, 2023
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Nov 7, 2023, 1:10PM
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Nov 7, 2023, 10:54AM
Hims & Hers shares are trading higher after the company reported better-than-expected Q3 sales results, raised FY23 guidance above estimates and announced a $50 million share repurchase program.
Benzinga Newsdesk
-
Nov 7, 2023, 9:31AM
Monday, November 06, 2023
MSP Recovery, Uber, Hims & Hers Health, Celsius, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro
-
Nov 6, 2023, 9:26PM
Hims & Hers Health Q3 Results Mixed But FY23 Revenue Guidance Raised, $50 Million Share Buyback
Ryan Gustafson
-
Nov 6, 2023, 4:50PM
Hims & Hers shares are trading higher after the company reported better-than-expected Q3 sales results, raised FY23 guidance above estimates and announced a $50 million share repurchase program.
Benzinga Newsdesk
-
Nov 6, 2023, 4:48PM
Hims & Hers Health Q3 2023 Gaap EPS $(0.04) Misses $(0.03) Estimate, Sales $226.70M Beat $220.05M Estimate
Benzinga Newsdesk
-
Nov 6, 2023, 4:23PM
Hims & Hers Health Raises 2023 Revenue Guidance To $868M-$873M vs $846.55M Est.
Benzinga Newsdesk
-
Nov 6, 2023, 4:09PM
Hims & Hers Health Q3 Revenue $226.7M vs $220.048M Est.
Benzinga Newsdesk
-
Nov 6, 2023, 4:07PM
Hims & Hers Health Raises Full Year 2023 Outlook
Benzinga Newsdesk
-
Nov 6, 2023, 4:06PM
Show more